Health and Healthcare

Allergan, Inc. : AGN

AGN

Stock Data

$193.02

$0.03 (0.02%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

All AGN Articles

189 Articles

Jon C. Ogg | Jun 2, 2020 at 11:29 AM EDT

Why AbbVie Could Have the Most Upside Among Big Pharma Stocks

Some mergers can add a nice shot in the arm for an acquirer. After years of being focused on Humira,…

Chris Lange | Jan 27, 2020 at 11:30 AM EST

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

These three health care companies included are expected to report their earnings on Tuesday morning.

Jon C. Ogg | Jan 22, 2020 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Broadcom, Cisco, IBM, Netflix, Rio Tinto, Tesla, Verizon, Visa, Xerox and More

Wednesday's top analyst upgrades, downgrades and initiations included Amazon.com, Boeing, Broadcom, Cisco Systems, IBM, Netflix, Rio Tinto, Tesla, Verizon, Visa…

Paul Ausick | Dec 24, 2019 at 7:55 AM EST

Allergan Gets FDA Approval for Migraine Treatment

The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain…

Jon C. Ogg | Nov 19, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack…

Jon C. Ogg | Oct 15, 2019 at 6:35 AM EDT

20 Dividend Stocks for All Baby Boomers to Retire On

Here are 20 companies that should offer investors who are retired or near retirement some added income to help make…

Chris Lange | Oct 14, 2019 at 10:05 AM EDT

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan has finally announced that its shareholders have voted to approve the company’s acquisition of AbbVie. The acquisition is expected…

Paul Ausick | Oct 1, 2019 at 12:00 PM EDT

Unusual Settlement Deal Proposed for Opioid Lawsuits

Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy…

Paul Ausick | Sep 5, 2019 at 7:50 AM EDT

Investors Torch Mallinckrodt on Report of Possible Bankruptcy Filing

Shares of drugmaker Mallinckrodt have lost more than 40% overnight following reports that the firm has hired restructuring advisors. A…

Jon C. Ogg | Jul 18, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Apple, Chipotle, Costco, Exxon, Netflix, Qualcomm, Ulta, US Bancorp and More

The top analyst upgrades, downgrades and initiations on Thursday included Advanced Micro Devices, Apple, Chipotle Mexican Grill, Costco, Exxon Mobil,…

Jon C. Ogg | Jul 16, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife, Slack, Wingstop and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife,…

Chris Lange | Jun 25, 2019 at 11:45 AM EDT

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan shares jumped on Tuesday after the company announced that it would be acquired by AbbVie in a cash and…

Jon C. Ogg | Jun 11, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More

The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook,…

Lee Jackson | May 10, 2019 at 9:25 AM EDT

Top Analyst Upgrades and Downgrades: 3D Systems, Allergan, Alcon, Booking, GoPro, IAC/Interactive, Lowe’s, Yelp and More

The top analyst upgrades, downgrades and initiations seen on Friday included 3D Systems, Allergan, Alcon, Booking, GoPro, IAC/Interactive, Lowe's and…

Jon C. Ogg | Mar 20, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan,…

1 2 3 … 13

Our $500K AI Portfolio

See us invest in our favorite AI stock ideas for free

Our Investment Portfolio

Live

Joel South | Dec 3, 2025 at 3:30 PM EST

Live: Snowflake (SNOW) Q3 Earnings Coverage

Live

Eric Bleeker | Dec 1, 2025 at 3:30 PM EST

Allergan, Inc. : AGN

AGN

$193.02

All AGN Articles

Why AbbVie Could Have the Most Upside Among Big Pharma Stocks

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Broadcom, Cisco, IBM, Netflix, Rio Tinto, Tesla, Verizon, Visa, Xerox and More

Allergan Gets FDA Approval for Migraine Treatment

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

20 Dividend Stocks for All Baby Boomers to Retire On

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Unusual Settlement Deal Proposed for Opioid Lawsuits

Investors Torch Mallinckrodt on Report of Possible Bankruptcy Filing

Top Analyst Upgrades and Downgrades: AMD, Apple, Chipotle, Costco, Exxon, Netflix, Qualcomm, Ulta, US Bancorp and More

Top Analyst Upgrades and Downgrades: AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife, Slack, Wingstop and More

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More

Top Analyst Upgrades and Downgrades: 3D Systems, Allergan, Alcon, Booking, GoPro, IAC/Interactive, Lowe’s, Yelp and More

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Should We Work Longer for Our Son’s Inheritance?

Exxon Mobil’s 43 Year Dividend Streak Looks Secure Despite Falling Earnings

3 Yield-Producing ETFs with Real Staying Power

Our $500K AI Portfolio

Live: Snowflake (SNOW) Q3 Earnings Coverage

Live: Credo Technology (CRDO) Q2 Earnings Coverage

The Real Loadout of an Army Ranger is Lethal and Precise

Should We Work Longer for Our Son’s Inheritance?

Allergan, Inc. : AGN

AGN

$193.02

All AGN Articles

Why AbbVie Could Have the Most Upside Among Big Pharma Stocks

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Broadcom, Cisco, IBM, Netflix, Rio Tinto, Tesla, Verizon, Visa, Xerox and More

Allergan Gets FDA Approval for Migraine Treatment

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

20 Dividend Stocks for All Baby Boomers to Retire On

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Unusual Settlement Deal Proposed for Opioid Lawsuits

Investors Torch Mallinckrodt on Report of Possible Bankruptcy Filing

Top Analyst Upgrades and Downgrades: AMD, Apple, Chipotle, Costco, Exxon, Netflix, Qualcomm, Ulta, US Bancorp and More

Top Analyst Upgrades and Downgrades: AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife, Slack, Wingstop and More

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More

Top Analyst Upgrades and Downgrades: 3D Systems, Allergan, Alcon, Booking, GoPro, IAC/Interactive, Lowe’s, Yelp and More

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Should We Work Longer for Our Son’s Inheritance?

Exxon Mobil’s 43 Year Dividend Streak Looks Secure Despite Falling Earnings

3 Yield-Producing ETFs with Real Staying Power

Our $500K AI Portfolio

Live: Snowflake (SNOW) Q3 Earnings Coverage

Live: Credo Technology (CRDO) Q2 Earnings Coverage